CNY 17.2
(-1.26%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 11.55 Billion | 11.22 Billion | 10.4 Billion | 8.35 Billion | 7.68 Billion | 7.31 Billion |
Cost of Revenue | 7.44 Billion | 7.52 Billion | 6.95 Billion | 5.29 Billion | 4.81 Billion | 4.56 Billion |
Gross Profit | 4.1 Billion | 3.7 Billion | 3.45 Billion | 3.05 Billion | 2.86 Billion | 2.74 Billion |
Operating Expenses | 2.54 Billion | 2.27 Billion | 2.08 Billion | 1.61 Billion | 1.56 Billion | 1.49 Billion |
Selling, General and Administrative Expenses | 1.84 Billion | 1.28 Billion | 1.19 Billion | 950.47 Million | 944.73 Million | 867.98 Million |
Research and Development Expenses | 413.25 Million | 358.1 Million | 289.89 Million | 207.02 Million | 185.11 Million | 190.66 Million |
Other Expenses | 58.12 Million | 631.29 Million | 600.73 Million | 460.64 Million | 439.68 Million | 441.28 Million |
Cost and Expenses | 10.04 Billion | 9.79 Billion | 9.03 Billion | 6.91 Billion | 6.38 Billion | 6.06 Billion |
Operating Income | 1.62 Billion | 1.28 Billion | 1.46 Billion | 1.52 Billion | 1.34 Billion | 1.23 Billion |
Interest Expense | 90.4 Million | 90.38 Million | 87.87 Million | 43.79 Million | 39.02 Million | 38.37 Million |
Income Tax Expense | 296.06 Million | 215.47 Million | 292.06 Million | 297.01 Million | 251.77 Million | 266.65 Million |
Earnings before Tax | 1.61 Billion | 1.29 Billion | 445.96 Million | 1.52 Billion | 1.34 Billion | 1.23 Billion |
Net Income | 1.26 Billion | 1.06 Billion | 122.57 Million | 1.19 Billion | 1.07 Billion | 959.07 Million |
Earnings Per Share Basic | 1.38 | 1.17 | 0.14 | 1.31 | 1.18 | 1.04 |
Earnings Per Share Diluted | 1.38 | 1.17 | 0.14 | 1.31 | 1.18 | 1.04 |
Weighted Average Shares Outstanding | 913.96 Million | 907.47 Million | 907.47 Million | 912.37 Million | 913.07 Million | 922.18 Million |
Weighted Average Shares Outstanding (Diluted) | 913.96 Million | 907.47 Million | 907.47 Million | 912.37 Million | 913.07 Million | 922.18 Million |
Gross Margin | 0.36 | 0.33 | 0.33 | 0.37 | 0.37 | 0.38 |
EBIT Margin | 0.19 | 0.18 | 0.18 | 0.22 | 0.21 | 0.21 |
Profit Margin | 0.11 | 0.09 | 0.01 | 0.14 | 0.14 | 0.13 |
EBITDA | 2.19 Billion | 1.9 Billion | 1 Billion | 1.93 Billion | 1.73 Billion | 1.56 Billion |
Earnings Before Tax Margin | 0.14 | 0.11 | 0.14 | 0.18 | 0.18 | 0.17 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 2.69 Billion | 2.79 Billion | 2.08 Billion | 3.42 Billion | 11.55 Billion | 3.45 Billion |
Cost of Revenue | 1.74 Billion | 1.79 Billion | 1.42 Billion | 2.3 Billion | 7.92 Billion | 2.18 Billion |
Gross Profit | 948.73 Million | 992.82 Million | 665.72 Million | 1.12 Billion | 3.63 Billion | 1.27 Billion |
Operating Expenses | 522.83 Million | 528.06 Million | 470.64 Million | 815.73 Million | 2.1 Billion | 662.68 Million |
Selling, General and Administrative Expenses | 427.62 Million | 415.71 Million | 383.17 Million | 595.63 Million | - | 786.51 Million |
Research and Development Expenses | 95.2 Million | 101.44 Million | 87.47 Million | 114.36 Million | - | 110.24 Million |
Other Expenses | - | -10.9 Million | -2.85 Million | -105.73 Million | -83.27 Million | -532.87 Thousand |
Cost and Expenses | 2.27 Billion | 2.32 Billion | 1.89 Billion | 3.12 Billion | 10.02 Billion | 2.84 Billion |
Operating Income | 425.9 Million | 464.76 Million | 195.08 Million | 306.65 Million | 1.53 Billion | 601.3 Million |
Interest Expense | 14.55 Million | 15.11 Million | 11.86 Million | 27.51 Million | 90.4 Million | 12.41 Million |
Income Tax Expense | 81.94 Million | 58.27 Million | 46.2 Million | 99.71 Million | 296.06 Million | 125.04 Million |
Earnings before Tax | 457.7 Million | 478.84 Million | 220.18 Million | 432.75 Million | 1.61 Billion | 600.77 Million |
Net Income | 356.99 Million | 399.13 Million | 165.46 Million | 308.84 Million | 1.26 Billion | 452.81 Million |
Earnings Per Share Basic | 0.37 | 0.41 | 0.17 | 0.33 | - | 0.50 |
Earnings Per Share Diluted | 0.37 | 0.41 | 0.17 | 0.33 | - | 0.50 |
Weighted Average Shares Outstanding | 963.04 Million | 963.04 Million | 958.15 Million | 934.59 Million | 913.96 Million | 907.47 Million |
Weighted Average Shares Outstanding (Diluted) | 963.04 Million | 963.04 Million | 958.15 Million | 934.59 Million | 913.96 Million | 907.47 Million |
Gross Margin | 0.35 | 0.36 | 0.32 | 0.33 | 0.31 | 0.37 |
EBIT Margin | 0.18 | 0.22 | 0.11 | 0.13 | - | 0.18 |
Profit Margin | 0.13 | 0.14 | 0.08 | 0.09 | 0.11 | 0.13 |
EBITDA | 472.26 Million | 609.85 Million | 232.03 Million | 445.32 Million | - | 616.4 Million |
Earnings Before Tax Margin | 0.16 | 0.17 | 0.09 | 0.09 | 0.13 | 0.17 |
BRGE
6791
UBS
MEDPLUS
WIB
WTII